Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation-Reference-Cited by-同舟云学术

Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation

Published:2021-04-08 Issue: Volume: Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Xu Hanchen,Van der Jeught Kevin^ORCID,Zhou Zhuolong,Zhang Lu,Yu Tao,Sun Yifan^ORCID,Li Yujing^ORCID,Wan Changlin,So Kaman,Liu Degang,Frieden Michael,Fang Yuanzhang^ORCID,Mosley Amber L.^ORCID,He Xiaoming^ORCID,Zhang Xinna,Sandusky George E.^ORCID,Liu Yunlong^ORCID,Meroueh Samy O.^ORCID,Zhang Chi^ORCID,Wijeratne Aruna B.^ORCID,Huang Cheng^ORCID,Ji Guang,Lu Xiongbin

Funder

Indiana University

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

http://www.jci.org/articles/view/146832/files/pdf

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in validation of combination treatment strategies for CRC using patient-derived organoids;Journal of Experimental & Clinical Cancer Research;2024-09-11

2. Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy;Clinical and Translational Medicine;2024-09

3. Immunoproteasome acted as immunotherapy ‘coffee companion’ in advanced carcinoma therapy;Frontiers in Immunology;2024-08-30

4. Nilotinib boosts the efficacy of anti-PDL1 therapy in colorectal cancer by restoring the expression of MHC-I;Journal of Translational Medicine;2024-08-14

5. Monocyte/Macrophage‐Mediated Transport of Dual‐Drug ZIF Nanoplatforms Synergized with Programmed Cell Death Protein‐1 Inhibitor Against Microsatellite‐Stable Colorectal Cancer;Advanced Science;2024-08-05